15 patents
Utility
Methods of Using Umbilical Cord Products for Treatment of Ocular Surface Disorders
4 Jan 24
Disclosed herein are methods of treating an ocular surface disease, disorder, or wound comprising applying an umbilical cord sheet and/or a controlled-release formulation to a tissue or surrounding tissue of an eye of a subject, such as the inferior fornix, superior fornix, and/or cornea.
Scheffer TSENG, Sean TIGHE, Ek Kia TAN, Jason Eric VEVODA
Filed: 2 Apr 21
Utility
Methods of Killing or Inhibiting the Growth of Cancer Cells
16 Mar 23
Provided herein, in certain embodiments, are compositions comprising an isolated heavy chain-hyaluronan/pentraxin 3 (“HC-HA/PTX3”) complex for use in methods of killing cancer cells.
Scheffer TSENG, Hua HE, Sean TIGHE, Kaustuv BASU
Filed: 12 Feb 21
Utility
Apparatuses and methods for treating ophthalmic diseases and disorders
28 Feb 23
The invention relates generally to the fields of biology and health sciences.
Scheffer Tseng, Ek Kia Tan
Filed: 2 Oct 19
Utility
Compositions containing HC-HA/PTX3 complexes and methods of use thereof
6 Dec 22
Provided herein are methods for the production of native and reconstituted hyaluronan (HA) complexes containing pentraxin-3 (PTX3) and heavy chain 1 (HC1) of inter alpha inhibitor (IαI).
Scheffer Tseng, Hua He, Sean Tighe, Suzhen Zhang, Ying-Tieng Zhu
Filed: 10 Jun 20
Utility
Compositions and Methods for Preventing the Proliferation and Epithelial-mesenchymal Transition of Epithelial Cells
9 Jun 22
Compositions and preparations of fetal support tissue that prevent or reduce the proliferation and epithelial-mesenchymal transition (EMT) of epithelial cells, wherein the epithelial cells may be human epithelial cells and the human epithelial cells may be conjunctival, retinal, corneal, limbal, or renal epithelial cells.
Scheffer TSENG, Ek Kia TAN, Hua HE
Filed: 18 Feb 22
Utility
Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
3 May 22
Compositions and preparations of fetal support tissue that prevent or reduce the proliferation and epithelial-mesenchymal transition (EMT) of epithelial cells, wherein the epithelial cells may be human epithelial cells and the human epithelial cells may be conjunctival, retinal, corneal, limbal, or renal epithelial cells.
Scheffer Tseng, Ek Kia Tan, Hua He
Filed: 23 May 19
Utility
Methods of Cellular Reprogramming
16 Dec 21
Disclosed herein are methods of cellular reprogramming, comprising contacting a cell with HC-HA/PTX3 for a time sufficient for cellular reprogramming of the phenotype of the cell to a different phenotype.
Scheffer TSENG, Frank E. YOUNG, Ying-Tieng ZHU, Szu Yu CHEN
Filed: 6 Nov 19
Utility
Compositions of Morselized Umbilical Cord And/or Amniotic Membrane and Methods of Use Thereof
23 Sep 21
The invention relates generally to the fields of biology and life sciences.
Scheffer TSENG, Lorraine CHUA
Filed: 7 Jun 21
Utility
Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof
14 Sep 21
The invention relates generally to the fields of biology and life sciences.
Scheffer Tseng, Lorraine Chua
Filed: 6 Oct 17
Utility
Compositions Containing HC-HA/PTX3 Complexes and Methods of Use Thereof
30 Sep 20
Provided herein are methods for the production of native and reconstituted hyaluronan (HA) complexes containing pentraxin-3 (PTX3) and heavy chain 1 (HC1) of inter alpha inhibitor (IαI).
Scheffer TSENG, Hua HE, Sean TIGHE, Suzhen ZHANG, Ying-Tieng ZHU
Filed: 9 Jun 20
Utility
Compositions containing HC-HA/PTX3 complexes and methods of use thereof
20 Jul 20
Provided herein are methods for the production of native and reconstituted hyaluronan (HA) complexes containing pentraxin-3 (PTX3) and heavy chain 1 (HC1) of inter alpha inhibitor (IαI).
Scheffer Tseng, Hua He, Sean Tighe, Suzhen Zhang, Ying-Tieng Zhu
Filed: 11 Feb 19
Utility
Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
27 Apr 20
Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice.
Scheffer Tseng, Hua He, Wei Li
Filed: 23 Jan 18
Utility
Apparatuses and Methods for Treating Ophthalmic Diseases and Disorders
26 Feb 20
The invention relates generally to the fields of biology and health sciences.
Scheffer TSENG, Ek Kia TAN
Filed: 1 Oct 19
Utility
Compositions and Methods for Preventing the Proliferation and Epithelial-mesenchymal Transition of Epithelial Cells
13 Nov 19
Compositions and preparations of fetal support tissue that prevent or reduce the proliferation and epithelial-mesenchymal transition (EMT) of epithelial cells, wherein the epithelial cells may be human epithelial cells and the human epithelial cells may be conjunctival, retinal, corneal, limbal, or renal epithelial cells.
Scheffer TSENG, Ek Kia TAN, Hua HE
Filed: 22 May 19
Utility
Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
30 Sep 19
Disclosed herein, are methods of preparing fetal support tissue powders.
Scheffer Tseng, Ek Kia Tan, Lorraine Chua
Filed: 30 May 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first